Biosino Bio-Technology and Science Incorporation (HKG:8247)

Hong Kong flag Hong Kong · Delayed Price · Currency is HKD
2.960
-0.050 (-1.66%)
At close: May 12, 2026
Market Cap435.57M +447.3%
Revenue (ttm)205.08M -29.9%
Net Income-56.91M
EPS-0.39
Shares Out144.71M
PE Ration/a
Forward PEn/a
Dividendn/a
Ex-Dividend Daten/a
Volumen/a
Average Volume126,300
Open3.010
Previous Close3.010
Day's Range2.960 - 3.010
52-Week Range0.510 - 7.000
Beta0.47
RSI33.56
Earnings DateMay 18, 2026

About HKG:8247

Biosino Bio-Technology and Science Incorporation, together with its subsidiaries, manufactures, sells, and distributes in-vitro diagnostic reagents in Mainland China. The company offers clinical chemistry reagents, including single and double reagents, calibrators, QC products, and washing solution detergents; Elisa kits; rapid tests; and analyzers. It also provides medical and medical inspection services; and produces and sells medical instruments. Biosino Bio-Technology and Science Incorporation Guangdong has a strategic cooperation agreement... [Read more]

Sector Healthcare
Founded 1988
Employees 471
Stock Exchange Hong Kong Stock Exchange
Ticker Symbol 8247
Full Company Profile

Financial Performance

In 2025, HKG:8247's revenue was 184.29 million, a decrease of -29.95% compared to the previous year's 263.07 million. Losses were -51.14 million, 20.2% more than in 2024.

Financial numbers in CNY Financial Statements